Prognostic analysis of patients with non-small cell lung cancer harboring exon 19 or 21 mutation in the epidermal growth factor gene and brain metastases

被引：0

作者：

Jing Wang

Zhiyan Liu

Qingsong Pang

Tian Zhang

Xi Chen

Puchun Er

Yuwen Wang

Ping Wang

Jun Wang

机构：

[1] Tianjin’s Clinical Research Centre for Cancer,Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cance

来源：

BMC Cancer | / 20卷

关键词：

Non-small cell lung cancer; Brain metastasis; mutation; Prognosis; Treatment;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] Prognostic analysis of patients with non-small cell lung cancer harboring exon 19 or 21 mutation in the epidermal growth factor gene and brain metastases
Wang, Jing
Liu, Zhiyan
Pang, Qingsong
Zhang, Tian
Chen, Xi
Er, Puchun
Wang, Yuwen
Wang, Ping
Wang, Jun
[J]. BMC CANCER, 2020, 20 (01)
[2] Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 mutation
Park, S. J.
Kim, H. T.
Lee, D. H.
Kim, K. P.
Kim, S. -W.
Suh, C.
Lee, J. S.
[J]. LUNG CANCER, 2012, 77 (03) : 556 - 560
[3] Analysis of metastases in non-small cell lung cancer patients with epidermal growth factor receptor mutation
Chen, Yu
Deng, Juan
Liu, Yu
Wang, Hao
Zhao, Sha
He, Yayi
Zhou, Caicun
[J]. ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (03)
[4] EFFICACY OF EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS FOR BRAIN METASTASIS IN NON-SMALL CELL LUNG CANCER PATIENTS HARBORING EITHER EXON 19 OR 21 MUTATIONS
Kim, Kyu-Pyo
Lee, Dae-Ho
Lee, Jungshin J.
Suh, Cheolwon
Kim, Sang-We
Lee, Jae Cheol
Choi, Chang-Min
Jang, Se Jin
Choi, Jene
[J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S657 - S657
[5] Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 mutations.
Kim, K.
Lee, D. H.
Lee, J.
Suh, C.
Kim, S.
Lee, J. C.
Choi, C.
Jang, S. J.
Choi, J.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[6] Comparison of clinical outcome between gefitinib and erlotinib treatment in patients with non-small cell lung cancer harboring an epidermal growth factor receptor exon 19 or exon 21 mutations
Lim, Sung Hee
Lee, Ji Yoon
Sun, Jong-Mu
Ahn, Jin Seok
Park, Keunchil
Ahn, Myung-Ju
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[7] COMPARISON OF CLINICAL OUTCOME BETWEEN GEFITINIB AND ERLOTINIB TREATMENT IN PATIENTS WITH NON-SMALL CELL LUNG CANCER HARBORING AN EPIDERMAL GROWTH FACTOR RECEPTOR EXON 19 OR EXON 21 MUTATIONS
Lim, Sung Hee
Lee, Ji Yun
Kim, Moonjin
Kim, Sungmin
Jung, Hyunae
Chang, Won Jin
Choi, Moon Ki
Sun, Jong-Mu
Hong, Jung Yong
Lee, Su Jin
Ahn, Jin Seok
Park, Keunchil
Ahn, Myung-Ju
[J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1204 - S1205
[8] ERLOTINIB ACCUMULATION IN BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER -VISUALIZATION BY PET IN A PATIENT HARBORING A MUTATION IN THE EPIDERMAL GROWTH FACTOR RECEPTOR
Weber, Britta
Winterdahl, Michael
Memon, Ashfaque
Sorensen, Boe S.
Keiding, Susanne
Sorensen, Leif
Nexo, Ebba
Meldgaard, Peter
[J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1124 - S1125
[9] Epidermal growth factor receptor mutations and brain metastases in non-small cell lung cancer
Zhao, Wei
Zhou, Wei
Rong, Li
Sun, Mao
Lin, Xing
Wang, Lulu
Wang, Shiqiang
Wang, Ying
Hui, Zhouguang
[J]. FRONTIERS IN ONCOLOGY, 2022, 12
[10] Good Clinical Response to Erlotinib in a Non-Small Cell Lung Cancer Patient Harboring Multiple Brain Metastases and a Double Active Somatic Epidermal Growth Factor Gene Mutation
Masago, Katsuhiro
Togashi, Yosuke
Fukudo, Masahide
Terada, Tomohiro
Irisa, Kaoru
Sakamori, Yuichi
Fujita, Shiro
Kim, Young Hak
Mio, Tadashi
Inuib, Kenichi
Mishima, Michiaki
[J]. CASE REPORTS IN ONCOLOGY, 2010, 3 (02): : 98 - 105

← 1 2 3 4 5 →